NASDAQ:BSGM - Biosig Technologies Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$4.4656 0.00 (0.00 %)
(As of 01/20/2019 04:00 PM ET)
Previous Close$4.4656
Today's Range$4.35 - $4.59
52-Week Range$3.21 - $7.88
Volume38,546 shs
Average Volume36,479 shs
Market Capitalization$74.41 million
P/E RatioN/A
Dividend YieldN/A
Beta0.69
BioSig Technologies, Inc., a development stage medical device company, engages in developing a proprietary biomedical signal processing technology platform to extract information from physiologic signals. Its product is PURE (Precise Uninterrupted Real-time evaluation of Electrograms) EP System, a surface electrocardiogram and intracardiac multichannel recording and analysis system that acquires, processes, and displays electrocardiogram and electrograms required during electrophysiology studies and catheter ablation procedures. It is also developing a library of software tools that are designed to be configured to fit the needs of electrophysiologists in various settings and for arrhythmia treatments. The company was founded in 2009 and is headquartered in Los Angeles, California.

Receive BSGM News and Ratings via Email

Sign-up to receive the latest news and ratings for BSGM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:BSGM
CUSIPN/A
Phone512-329-2643

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value($0.28) per share

Profitability

Net Income$-12,690,000.00

Miscellaneous

Employees14
Market Cap$74.41 million
OptionableNot Optionable

Biosig Technologies (NASDAQ:BSGM) Frequently Asked Questions

What is Biosig Technologies' stock symbol?

Biosig Technologies trades on the NASDAQ under the ticker symbol "BSGM."

How were Biosig Technologies' earnings last quarter?

Biosig Technologies, Inc. (NASDAQ:BSGM) announced its quarterly earnings results on Friday, August, 12th. The company reported ($0.32) EPS for the quarter. View Biosig Technologies' Earnings History.

What price target have analysts set for BSGM?

1 brokers have issued 1 year price targets for Biosig Technologies' shares. Their forecasts range from $14.00 to $14.00. On average, they expect Biosig Technologies' share price to reach $14.00 in the next twelve months. This suggests a possible upside of 213.5% from the stock's current price. View Analyst Price Targets for Biosig Technologies.

What is the consensus analysts' recommendation for Biosig Technologies?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Biosig Technologies in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Biosig Technologies.

Has Biosig Technologies been receiving favorable news coverage?

Headlines about BSGM stock have been trending neutral recently, according to InfoTrie Sentiment. InfoTrie ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Biosig Technologies earned a daily sentiment score of 0.1 on InfoTrie's scale. They also gave media stories about the company a news buzz of 4.0 out of 10, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

Who are some of Biosig Technologies' key competitors?

Who are Biosig Technologies' key executives?

Biosig Technologies' management team includes the folowing people:
  • Mr. Kenneth L. Londoner M.B.A., MBA, Founder, CEO & Exec. Chairman (Age 50)
  • Mr. Steven Chaussy, Chief Financial Officer (Age 64)
  • Ms. Lora Mikolaitis, VP of Admin. (Age 45)
  • Mrs. Tiffini Wittwer, Chief Regulatory & Compliance Officer
  • Ms. Natasha Drapeau, Exec. VP

Who are Biosig Technologies' major shareholders?

Biosig Technologies' stock is owned by many different of institutional and retail investors. Top institutional investors include Virtu Financial LLC (0.07%). Company insiders that own Biosig Technologies stock include Andrew Lawrence Filler, Donald E Foley, Joseph Rafferty, Kenneth L Londoner, Lora Mikolaitis, Patrick Joseph Gallagher and Steve Chaussy. View Institutional Ownership Trends for Biosig Technologies.

Which major investors are buying Biosig Technologies stock?

BSGM stock was acquired by a variety of institutional investors in the last quarter, including Virtu Financial LLC. Company insiders that have bought Biosig Technologies stock in the last two years include Andrew Lawrence Filler, Donald E Foley, Joseph Rafferty, Kenneth L Londoner, Patrick Joseph Gallagher and Steve Chaussy. View Insider Buying and Selling for Biosig Technologies.

How do I buy shares of Biosig Technologies?

Shares of BSGM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Biosig Technologies' stock price today?

One share of BSGM stock can currently be purchased for approximately $4.4656.

How big of a company is Biosig Technologies?

Biosig Technologies has a market capitalization of $74.41 million. Biosig Technologies employs 14 workers across the globe.

What is Biosig Technologies' official website?

The official website for Biosig Technologies is http://www.biosigtech.com.

How can I contact Biosig Technologies?

Biosig Technologies' mailing address is 12424 WILSHIRE BOULEVARD SUITE 745, LOS ANGELES CA, 90025. The company can be reached via phone at 512-329-2643 or via email at [email protected]


MarketBeat Community Rating for Biosig Technologies (NASDAQ BSGM)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  3 (Vote Outperform)
Underperform Votes:  3 (Vote Underperform)
Total Votes:  6
MarketBeat's community ratings are surveys of what our community members think about Biosig Technologies and other stocks. Vote "Outperform" if you believe BSGM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BSGM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/20/2019 by MarketBeat.com Staff

Featured Article: Swap

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel